# US 2015/0150153 A1 · Artificial oocyte activation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0150153 A1
- Document ID: US20150150153A1
- Status: Published application
- Kind: A1
- Application number: 14/554,504
- Filed: 2014-11-26
- Published: 2015-05-28
- Earliest claimed: 2013-11-27
- Assignees: The Curators of the University of Missouri
- Inventors: Kiho Lee; Randall S. Prather
- Web page: https://patentgrep.com/patent/US20150150153A1

## CPC

- C12N 5/0609: {Oocytes, oogonia (fertilised oocytes C12N5/0604)}
- A01K 67/0273: Cloned vertebrates
- C12N 15/877: Techniques for producing new mammalian cloned embryos
- C12N 15/8778: {Swine embryos}
- A01K 2227/108: Swine
- C12N 2500/14: Calcium; Ca chelators; Calcitonin
- C12N 2500/22: Zinc; Zn chelators
- C12N 2501/405: Cell cycle regulated proteins, e.g. cyclins, cyclin-dependant kinases
- C12N 2517/04: Cells produced using nuclear transfer
- C12N 2517/10: Conditioning of cells for in vitro fecondation or nuclear transfer
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention provides novel methods for improving the efficiency of artificial activation of unfertilized mammalian oocytes by reducing the intracellular concentration of Zn2+ in the oocyte. The methods of the invention may additionally comprise a preceding step of increasing the intracellular concentration of Ca2+ in the oocyte prior to reduction of the intracellular Zn2+ concentration. The invention further provides unfertilized oocytes activated by the disclosed methods and viable mammalian animals produced from unfertilized oocytes activated by the disclosed methods.

## Claims

### Claim 1

A method of activating an unfertilized livestock or domestic mammalian oocyte comprising decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety.

### Claim 2 (depends on 1)

The method of claim 1, wherein the Zn2+ binding moiety comprises a concentration of between approximately 10 μM to approximately 500 μM.

### Claim 3 (depends on 2)

The method of claim 2, wherein the Zn2+ binding moiety comprises a concentration of between approximately 100 μM to approximately 250 μM.

### Claim 4 (depends on 3)

The method of claim 3, wherein the Zn2+ binding moiety comprises a concentration of approximately 200 μM.

### Claim 5 (depends on 1)

The method of claim 1, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising between approximately 1 minute to approximately 5 hours.

### Claim 6 (depends on 5)

The method of claim 5, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising between approximately 30 minutes to approximately 2.5 hours.

### Claim 7 (depends on 6)

The method of claim 6, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising approximately 30 minutes.

### Claim 8 (depends on 1)

The method of claim 1, further comprising the step of increasing intracellular Ca2+ concentration of the oocyte prior to decreasing the intracellular Zn2+ concentration of the oocyte.

### Claim 9 (depends on 8)

The method of claim 8, wherein the intracellular Ca2+ concentration of the oocyte is not increased in an amount sufficient to induce oocyte activation.

### Claim 10 (depends on 9)

The method of claim 9, wherein the intracellular Ca2+ concentration of the oocyte is increased approximately ten times less than the amount sufficient to induce oocyte activation.

### Claim 11 (depends on 9)

The method of claim 9, wherein the Zn2+ binding moiety comprises a concentration of between approximately 1 μM to approximately 500 μM.

### Claim 12 (depends on 11)

The method of claim 11, wherein the Zn2+ binding moiety comprises a concentration of between approximately 100 μM to approximately 200 μM.

### Claim 13 (depends on 12)

The method of claim 12, wherein the Zn2+ binding moiety comprises a concentration of approximately 200 μM.

### Claim 14 (depends on 9)

The method of claim 9, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising between approximately 1 minutes to approximately 12 hours.

### Claim 15 (depends on 14)

The method of claim 14, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising between approximately 10 minutes to approximately 2 hours.

### Claim 16 (depends on 15)

The method of claim 15, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising approximately 30 minutes.

### Claim 17 (depends on 8)

The method of claim 8, wherein the intracellular Ca2+ concentration of the oocyte is increased in an amount sufficient to induce oocyte activation.

### Claim 18 (depends on 17)

The method of claim 17, wherein the Zn2+ binding moiety comprises a concentration of between approximately 0.1 μM to approximately 100 μM.

### Claim 19 (depends on 18)

The method of claim 18, wherein the Zn2+ binding moiety comprises a concentration of between approximately 1 μM to approximately 10 μM.

### Claim 20 (depends on 19)

The method of claim 19, wherein the Zn2+ binding moiety comprises a concentration of approximately 5 μM.

### Claim 21 (depends on 19)

The method of claim 19, wherein the Zn2+ binding moiety comprises a concentration of approximately 10 μM.

### Claim 22 (depends on 17)

The method of claim 17, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising between approximately 1 minutes to approximately 5 hours.

### Claim 23 (depends on 22)

The method of claim 22, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising between approximately 10 minutes to approximately 30 minutes.

### Claim 24 (depends on 23)

The method of claim 23, wherein the Zn2+ binding moiety contacts the oocyte for a period of time comprising approximately 30 minutes.

### Claim 25 (depends on 8)

The method of claim 8, wherein the intracellular Ca2+ concentration of the oocyte is increased by chemical or physical means or a combination thereof that induce calcium entry into the oocyte or release of internal calcium stores.

### Claim 26 (depends on 25)

The method of claim 25, wherein the increase in the intracellular Ca2+ concentration of the oocyte by chemical means comprises treatment with a calcium containing medium, a calcium salt containing medium, thimerosal containing medium, ethanol containing medium, inositol trisphosphate containing medium, a calcium ionophore containing medium, a sodium-free medium or a combination thereof.

### Claim 27 (depends on 26)

The method of claim 26, wherein the chemical treatment comprises treatment with a medium comprising a Ca2+ concentration of between approximately 0.1 mM and approximately 250 mM.

### Claim 28 (depends on 27)

The method of claim 27, wherein the chemical treatment comprises treatment with a medium comprising a Ca2+ concentration of between approximately 0.1 mM and 1 mM.

### Claim 29 (depends on 25)

The method of claim 25, wherein the increase in the intracellular Ca2+ concentration of the oocyte by physical means comprises application of an electrical stimulus.

### Claim 30 (depends on 1)

The method of claim 1, wherein the Zn2+ binding moiety comprises TPEN (N,N,N′,N′-tetrakis(2-pyridylmethyl)ethane-1,2-diamine).

### Claim 31 (depends on 1)

The method of claim 1, wherein the unfertilized livestock or domestic mammalian oocyte is a nuclear transfer oocyte.

### Claim 32 (depends on 1)

The method of claim 1, wherein the unfertilized livestock or domestic mammalian oocyte is selected from the group consisting of a porcine oocyte, bovine oocyte, ovine oocyte, goat oocyte, horse oocyte, canine oocyte and feline oocyte.

### Claim 33 (depends on 1)

A parthenogenetic oocyte activated by the method of claim 1.

### Claim 34 (depends on 1)

A nuclear transfer oocyte activated by the method of claim 1.

### Claim 35 (depends on 1)

A viable livestock or domestic mammalian animal produced from an unfertilized livestock or domestic mammalian oocyte activated by the method of claim 1, wherein said animal comprises the genomic DNA from a donor cell other than the oocyte and the mitochondrial DNA from the oocyte.

### Claim 36 (depends on 35)

The viable livestock or domestic mammalian animal of claim 35, wherein the animal comprises epigenetic features different from the epigenetic features of the donor cell.

### Claim 37 (depends on 36)

The viable livestock or domestic mammalian animal of claim 36, wherein the epigenetic features different from the epigenetic features of the donor cell are DNA methylation sites or histone modifications.

### Claim 38 (depends on 35)

The viable livestock or domestic mammalian animal of claim 35, wherein the animal is selected from the group consisting of a porcine animal, bovine animal, ovine animal, goat, horse, dog and cat.

### Claim 39

A method of activating an unfertilized mammalian oocyte comprising increasing intracellular Ca2+ concentration of the oocyte by contacting the oocyte with a medium comprising a calcium concentration of approximately 0.1 mM and decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety at a concentration of approximately 200 μM for a period of time comprising approximately 30 minutes.

### Claim 40

A method of activating an unfertilized mammalian oocyte comprising increasing intracellular Ca2+ concentration of the oocyte by contacting the oocyte with a medium comprising a calcium concentration of approximately 1.0 mM and decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety at a concentration of approximately 5 μM for a period of time comprising approximately 30 minutes.

### Claim 41

A method of activating an unfertilized mammalian oocyte comprising increasing intracellular Ca2+ concentration of the oocyte by contacting the oocyte with a medium comprising a calcium concentration of approximately 1.0 mM and decreasing intracellular Zn2+ concentration of the oocyte by contacting the oocyte with a Zn2+ binding moiety at a concentration of approximately 10 μM for a period of time comprising approximately 30 minutes.
